News Release

Zogenix to Participate in Leerink Partners 7th Annual Global Healthcare Conference


EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, and Michael P. Smith, Executive Vice President, Chief Financial Officer & Treasurer and Secretary, will present a corporate update at the Leerink Partners 7th Annual Global Healthcare Conference, being held in New York City from February 14-15, 2018.

Leerink Partners 7thAnnual Annual Global Healthcare Conference -- Zogenix Presentation Details

Date:  Thursday, February 15, 2018                        
Time:  9:00 am Eastern Time / 6:00 am Pacific Time         
Location:  New York, NY - Lotte New York Palace Hotel

The presentation will be webcast live and archived for 90 days on Zogenix's Investor Relations website at

About Zogenix
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

For more information, visit

CONTACT:     Investors: Andrew McDonald
Founding Partner, LifeSci Advisors LLC
646-597-6987 |

Primary Logo

Source: Zogenix, Inc.